Therapies for viral hepatitis:
Gespeichert in:
| Format: | Buch |
|---|---|
| Sprache: | English |
| Veröffentlicht: |
London ; Munich [u.a.]
Internat. Medical
1998
|
| Schlagworte: | |
| Online-Zugang: | Inhaltsverzeichnis |
| Beschreibung: | XXII, 451 S. graph. Darst. |
| ISBN: | 1901769011 |
Internformat
MARC
| LEADER | 00000nam a2200000 c 4500 | ||
|---|---|---|---|
| 001 | BV012232306 | ||
| 003 | DE-604 | ||
| 005 | 20000511 | ||
| 007 | t | ||
| 008 | 981029s1998 d||| |||| 00||| eng d | ||
| 020 | |a 1901769011 |9 1-901769-01-1 | ||
| 035 | |a (OCoLC)41659229 | ||
| 035 | |a (DE-599)BVBBV012232306 | ||
| 040 | |a DE-604 |b ger |e rakddb | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-355 | ||
| 082 | 0 | |a 616.3623 |2 21 | |
| 084 | |a YC 5615 |0 (DE-625)153237:12921 |2 rvk | ||
| 245 | 1 | 0 | |a Therapies for viral hepatitis |c ed. by Raymond F. Schinazi ... |
| 264 | 1 | |a London ; Munich [u.a.] |b Internat. Medical |c 1998 | |
| 300 | |a XXII, 451 S. |b graph. Darst. | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 650 | 7 | |a Doencas infecciosas e parasitarias |2 larpcal | |
| 650 | 7 | |a Hépatites virales - Chimiothérapie |2 ram | |
| 650 | 7 | |a Hépatites virales - Diagnostic |2 ram | |
| 650 | 7 | |a Hépatites virales - Thérapeutique |2 ram | |
| 650 | 2 | |a Hépatites virales humaines - Thérapeutique | |
| 650 | 2 | |a Virus des hépatites | |
| 650 | 4 | |a Hepatitis Viruses | |
| 650 | 4 | |a Hepatitis, Viral | |
| 650 | 4 | |a Hepatitis, Viral |x Chemotherapy | |
| 650 | 4 | |a Hepatitis, Viral |x Diagnosis | |
| 650 | 4 | |a Hepatitis, Viral |x Treatment | |
| 650 | 4 | |a Hepatitis, Viral, Human |x therapy | |
| 650 | 0 | 7 | |a Therapie |0 (DE-588)4059798-2 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Virushepatitis |0 (DE-588)4290453-5 |2 gnd |9 rswk-swf |
| 655 | 7 | |0 (DE-588)4143413-4 |a Aufsatzsammlung |2 gnd-content | |
| 689 | 0 | 0 | |a Virushepatitis |0 (DE-588)4290453-5 |D s |
| 689 | 0 | 1 | |a Therapie |0 (DE-588)4059798-2 |D s |
| 689 | 0 | |5 DE-604 | |
| 700 | 1 | |a Schinazi, Raymond F. |e Sonstige |4 oth | |
| 856 | 4 | 2 | |m HBZ Datenaustausch |q application/pdf |u http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=008288440&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |3 Inhaltsverzeichnis |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-008288440 | ||
Datensatz im Suchindex
| _version_ | 1804126848791085056 |
|---|---|
| adam_text | Contents
PREFACE xi
ACKNOWLEDGEMENTS xiii
BIOGRAPHIES xv
CONTRIBUTORS xvii
SECTION I: EPIDEMIOLOGY AND NATURAL HISTORY
1. Epidemiology and prevention of chronic hepatitis B and C 3 8
in North and South America
Miriam J Alter and Craig N Shapiro
2. Epidemiology and control of hepatitis B and C in eastern Asia 9 14
Zhi Yi Xu, Shou jun Zhao, Richard T Mahoney, Xin qing Deng, Ximin Lin,
Jie Xu and Ding Ding
3. Prevalence of hepatitis B and C in Egypt and Africa 15 24
Mohammed A Attia
4. Magnitude of hepatitis B and C in Latin America 25 34
Flair Jose Carrilho and Maria Cassia Jacintho Mendes Correa
5. Hepatitis B and C virus infections in Mexico: genotypes and geographical 35—41
distribution in blood donors and patients with liver disease
Cosme Alvarado Esquivel, Ann Wyseur, Flor de Maria Herrera Ortiz, Lilia Ruiz Maya,
Rosario Ruiz Astorga, Angel Zarate Aguilar, Eduardo Carrillo Maravilla,
Rodolfo Herrera Luna, Maria del Carmen Morales Macedo, Geert Maertens
and Lieven Stuyver
6. Natural history and clinical aspects of hepatitis C virus infection 43 50
Harvey Alter
SECTION II: IMMUNOLOGY, PATHOGENESIS AND EMERGING VIRUSES
7. The immunopathogenesis of hepatitis B virus infection 53 64
Margaret James Koziel
8. Pathogenesis of chronic hepatitis C virus infection 65 76
David R Nelson and Johnson YN Lau
9. Pathomorphology and apoptosis in viral hepatitis 77 86
Zsuzsa Schaff, Gdbor Lotz, Gerald Eder and Rolf Schulte Hermann
10. Hepatitis delta virus: molecular biology, pathogenesis and immunology 87 92
John L Casey
11. Molecular cloning and disease associations of hepatitis G virus 93 99
Jungsuh P Kim, Kirk E Fry and John Wages Jr for the HGV Study Group
vii
SECTION III: GENETICS AND VIRAL DIAGNOSIS
12. Molecular tools for the treatment of hepatitis C 103 113
Jean Michel Pawlotsky and David R Gretch
13. Utility of hepatitis virus nucleic acid assays in therapeutic drug trials 115 127
Maurice Rosenstraus, Karen Gutekunst and Beverly Dale
14. New developments in hepatitis C diagnostics and monitoring 129 132
Judith C Wither
15. Genomic structure and variability of hepatitis C virus 133 138
Jens Bukh and Robert H Purcell
16. A line probe assay for hepatitis B virus genotypes 139 145
Caroline Van Geyt, Sija De Gendt, Annelies Rombout, Ann Wyseur,
Geert Maertens, Rudi Rossau and Lieven Stuyver
SECTION IV: ANIMAL MODELS FOR HEPATITIS B AND C
17. Hepatitis C and hepatitis B animal models 149 159
Shlomo Dagan, Ehud llan and Raymond F Schinazi
18. Transgenic mice as a chemotherapeutic model for hepatitis B virus infection 161 170
John D Morrey, Brent E Korba and Robert W Sidwell
19. The woodchuck in preclinical assessment of therapy for hepatitis B 171 176
virus infection
Bud C Tennant, Simon F Peek, Ilia A Tochkov, Betty H Baldwin,
William E Hornbuckle, Brent E Korba, Paul J Cote and John L Gerin
20. Antiviral therapy for chronic hepadnavirus infections 177 184
William S Mason, Tianlun Zhou, Fred Nunes, Lynn D Condreay,
Samuel Litwin and Jesse Summers
21. Maternal and foetal vaccination strategies for hepatitis B surface antigen 185 193
in non human primate models: evaluation of therapeutic modalities
during pregnancy
Allison M Watts, John R Stanley, Michael H Shearer and Ronald C Kennedy
22. Antiviral and anti proliferative activities of a interferons in experimental 195 203
hepatitis B virus infections
/ David Gangemi, Brent E Korba, Bud C Tennant, John L Gerin, Paul J Cote,
Hiroyuki Veda and Gilbert Jay
SECTION V: ANTIVIRAL TARGETS FOR HEPATITIS C
23. Molecular virology of hepatitis C virus: an update with respect to potential 207 217
antiviral targets
Keril J Blight, Alexander A Kolykhalov, Karen E Reed, Eugene V Agapov
and Charles M Rice
24. Targets for inhibition of hepatitis C virus replication 219 227
Margaret Littlejohn, Stephen Locarnini and Angeline Bartholomeusz
25. Helicase, a target for novel inhibitors of hepatitis C virus 229 233
Nanhua Yao and Patricia C Weber
26. The hepatitis C virus NS3 proteinase: structure and function of a 235 245
zinc containing serine proteinase
Raffaele De Francesco, Antonello Pessi and Christian Steinkiihler
27. Conformational changes in hepatitis C virus NS3 proteinase during 247 254
NS4A complexation: correlation with enhanced cleavage and
implications for inhibitor design
Robert A Love, Hans E Parge, John A Wickersham, Zdenek Hostomsky,
Noriyuki Habuka, Ellen W Moomaw, Tsuyoshi Adachi, Steve Margosiak,
Eleanor Dagostino and Zuzana Hostomska
28. Hepatitis C virus non structural region 5A protein is a potent 255 262
transcriptional activator
Naoya Kato, Keng Hsin Lan, Suzane Kioko Ono Nita, Hideo Yoshida,
Yasushi Shiratori and Masao Omata
29. Protein processing of hepatitis C virus and investigation of the effects of 263 269
viral proteins on cell proliferation
Shinya Satoh, Masami Hirota, Michiharu Inudoh, Nobuyuki Kato,
Makoto Hijikata and Kunitada Shimotohno
SECTION VI: DRUG DISCOVERY
PART A: Preclinical Investigation
30. The mechanism of action and cellular pharmacology of anti hepatitis B 273 283
virus agents
Phillip A Furtnan and Raymond F Schinazi
31. Pathogenic effects of antiviral therapy in chronic hepatitis B virus infection 285 302
Jia Yee Lee, Danni Colledge and Stephen Locarnini
32. Preclinical investigation of l FMAU as an anti hepatitis B virus agent 303 312
Chung K Chu, F Douglas Boudinot, Simon F Peek, Joon H Hong,
Yongseok Choi, Brent E Korba, John L Gerin, Paul ] Cote,
Bud C Tennant and Yung Chi Cheng
33. A rational strategy for the design of anti hepatitis B virus 313 319
nucleotide derivatives
Christian Perigaud, Gilles Gosselin and Jean Louis Imbach
34. Cellular pharmacology of lamivudine in hepatocyte primary cultures 321 325
Erika Cretton Scott and Jean Pierre Sommadossi
PART B: Resistance and Quasispecies
35. Influence of reverse transcriptase YMDD motif variants on replication 329 333
and lamivudine resistance of hepatitis B virus
Suzane Kioko Ono Nita, Naoya Kato, Yasushi Shiratori, Keng Hsin Lan,
Hideo Yoshida, Flair Jose Carrilho and Masao Omata
36. The consequences of quasispecies heterogeneity and within host ecology 335 343
for antiviral therapy of hepatitis B virus
Nigel J Burroughs, David A Rand, Deenan Pillay, Elwyn Elias and David Mutimer
ix
SECTION VII: CLINICAL AND THERAPEUTIC STRATEGIES
PART A: The Immunocompetent Individual
37. Mathematical modelling of chronic hepatitis B and C virus infection: 347 352
a basis for planning new approaches to therapy
Howard C Thomas
38. Treatment of hepatitis B virus with lamivudine 353 363
Winnie WS Wong and D Lome J Tyrrell
39. Treatment of chronic hepatitis B with famciclovir 365 370
Christian Trepo and Fabien Zoulim
40. Treatment of chronic hepatitis C with interferon: 1998 update 371 378
Thierry Poynard, Joseph Moussali, Thierry Thevenot, Vlad Ratziu and Pierre Opolon
41. Interferon plus thymosin oc 1 treatment of chronic hepatitis C infection: 379 383
a meta analysis
Kenneth E Sherman and Susan N Sherman
42. Primary response to interferon a plus ribavirin in non responders and 385 386
relapsers with chronic liver disease owing to hepatitis C virus
Antonio Ascione, Carmine Canestrini, Silvia Astretto, Massimo De Luca,
Alfonso Galeota Lanza, Filomena Morisco, Concetta Tuccillo, Nicola Caporaso,
Francesca Froio, Piero Piergrossi and Carmelo D Asero
PART B: Transplant Patients
43. Hepatitis C virus in the transplant setting 389 402
Marina Berenguer and Teresa L Wright
44. Liver transplantation and hepatitis B: prophylaxis and treatment of 403 412
re infection with new antiviral agents
Martin Kriiger and Michael P Manns
PART C: Coinfections
45. Effect of lamivudine on hepatitis B virus human immunodeficiency virus 415 416
coinfected patients from the CAESAR study
David A Cooper
46. Coinfection with hepatitis B and C viruses 417 422
Patrizia Pontisso, Martina Gerotto, Luisa Benvegnu, Liliana Chemello
and Alfredo Alberti
PART D: Hepatocellular Carcinoma
47. Relationship between infection with hepatitis C virus and hepatocellular 425 429
carcinoma in Japan
Shiro lino
48. Factors influencing the course of hepatitis B virus infection 431 434
Baruch S Blumberg
INDEX 437 451
|
| any_adam_object | 1 |
| building | Verbundindex |
| bvnumber | BV012232306 |
| classification_rvk | YC 5615 |
| ctrlnum | (OCoLC)41659229 (DE-599)BVBBV012232306 |
| dewey-full | 616.3623 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 616 - Diseases |
| dewey-raw | 616.3623 |
| dewey-search | 616.3623 |
| dewey-sort | 3616.3623 |
| dewey-tens | 610 - Medicine and health |
| discipline | Medizin |
| format | Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01952nam a2200505 c 4500</leader><controlfield tag="001">BV012232306</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20000511 </controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">981029s1998 d||| |||| 00||| eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">1901769011</subfield><subfield code="9">1-901769-01-1</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)41659229</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV012232306</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakddb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-355</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">616.3623</subfield><subfield code="2">21</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">YC 5615</subfield><subfield code="0">(DE-625)153237:12921</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Therapies for viral hepatitis</subfield><subfield code="c">ed. by Raymond F. Schinazi ...</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">London ; Munich [u.a.]</subfield><subfield code="b">Internat. Medical</subfield><subfield code="c">1998</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">XXII, 451 S.</subfield><subfield code="b">graph. Darst.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Doencas infecciosas e parasitarias</subfield><subfield code="2">larpcal</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Hépatites virales - Chimiothérapie</subfield><subfield code="2">ram</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Hépatites virales - Diagnostic</subfield><subfield code="2">ram</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Hépatites virales - Thérapeutique</subfield><subfield code="2">ram</subfield></datafield><datafield tag="650" ind1=" " ind2="2"><subfield code="a">Hépatites virales humaines - Thérapeutique</subfield></datafield><datafield tag="650" ind1=" " ind2="2"><subfield code="a">Virus des hépatites</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Hepatitis Viruses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Hepatitis, Viral</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Hepatitis, Viral</subfield><subfield code="x">Chemotherapy</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Hepatitis, Viral</subfield><subfield code="x">Diagnosis</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Hepatitis, Viral</subfield><subfield code="x">Treatment</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Hepatitis, Viral, Human</subfield><subfield code="x">therapy</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Therapie</subfield><subfield code="0">(DE-588)4059798-2</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Virushepatitis</subfield><subfield code="0">(DE-588)4290453-5</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)4143413-4</subfield><subfield code="a">Aufsatzsammlung</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Virushepatitis</subfield><subfield code="0">(DE-588)4290453-5</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Therapie</subfield><subfield code="0">(DE-588)4059798-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Schinazi, Raymond F.</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="m">HBZ Datenaustausch</subfield><subfield code="q">application/pdf</subfield><subfield code="u">http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=008288440&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA</subfield><subfield code="3">Inhaltsverzeichnis</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-008288440</subfield></datafield></record></collection> |
| genre | (DE-588)4143413-4 Aufsatzsammlung gnd-content |
| genre_facet | Aufsatzsammlung |
| id | DE-604.BV012232306 |
| illustrated | Illustrated |
| indexdate | 2024-07-09T18:23:59Z |
| institution | BVB |
| isbn | 1901769011 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-008288440 |
| oclc_num | 41659229 |
| open_access_boolean | |
| owner | DE-355 DE-BY-UBR |
| owner_facet | DE-355 DE-BY-UBR |
| physical | XXII, 451 S. graph. Darst. |
| publishDate | 1998 |
| publishDateSearch | 1998 |
| publishDateSort | 1998 |
| publisher | Internat. Medical |
| record_format | marc |
| spelling | Therapies for viral hepatitis ed. by Raymond F. Schinazi ... London ; Munich [u.a.] Internat. Medical 1998 XXII, 451 S. graph. Darst. txt rdacontent n rdamedia nc rdacarrier Doencas infecciosas e parasitarias larpcal Hépatites virales - Chimiothérapie ram Hépatites virales - Diagnostic ram Hépatites virales - Thérapeutique ram Hépatites virales humaines - Thérapeutique Virus des hépatites Hepatitis Viruses Hepatitis, Viral Hepatitis, Viral Chemotherapy Hepatitis, Viral Diagnosis Hepatitis, Viral Treatment Hepatitis, Viral, Human therapy Therapie (DE-588)4059798-2 gnd rswk-swf Virushepatitis (DE-588)4290453-5 gnd rswk-swf (DE-588)4143413-4 Aufsatzsammlung gnd-content Virushepatitis (DE-588)4290453-5 s Therapie (DE-588)4059798-2 s DE-604 Schinazi, Raymond F. Sonstige oth HBZ Datenaustausch application/pdf http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=008288440&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA Inhaltsverzeichnis |
| spellingShingle | Therapies for viral hepatitis Doencas infecciosas e parasitarias larpcal Hépatites virales - Chimiothérapie ram Hépatites virales - Diagnostic ram Hépatites virales - Thérapeutique ram Hépatites virales humaines - Thérapeutique Virus des hépatites Hepatitis Viruses Hepatitis, Viral Hepatitis, Viral Chemotherapy Hepatitis, Viral Diagnosis Hepatitis, Viral Treatment Hepatitis, Viral, Human therapy Therapie (DE-588)4059798-2 gnd Virushepatitis (DE-588)4290453-5 gnd |
| subject_GND | (DE-588)4059798-2 (DE-588)4290453-5 (DE-588)4143413-4 |
| title | Therapies for viral hepatitis |
| title_auth | Therapies for viral hepatitis |
| title_exact_search | Therapies for viral hepatitis |
| title_full | Therapies for viral hepatitis ed. by Raymond F. Schinazi ... |
| title_fullStr | Therapies for viral hepatitis ed. by Raymond F. Schinazi ... |
| title_full_unstemmed | Therapies for viral hepatitis ed. by Raymond F. Schinazi ... |
| title_short | Therapies for viral hepatitis |
| title_sort | therapies for viral hepatitis |
| topic | Doencas infecciosas e parasitarias larpcal Hépatites virales - Chimiothérapie ram Hépatites virales - Diagnostic ram Hépatites virales - Thérapeutique ram Hépatites virales humaines - Thérapeutique Virus des hépatites Hepatitis Viruses Hepatitis, Viral Hepatitis, Viral Chemotherapy Hepatitis, Viral Diagnosis Hepatitis, Viral Treatment Hepatitis, Viral, Human therapy Therapie (DE-588)4059798-2 gnd Virushepatitis (DE-588)4290453-5 gnd |
| topic_facet | Doencas infecciosas e parasitarias Hépatites virales - Chimiothérapie Hépatites virales - Diagnostic Hépatites virales - Thérapeutique Hépatites virales humaines - Thérapeutique Virus des hépatites Hepatitis Viruses Hepatitis, Viral Hepatitis, Viral Chemotherapy Hepatitis, Viral Diagnosis Hepatitis, Viral Treatment Hepatitis, Viral, Human therapy Therapie Virushepatitis Aufsatzsammlung |
| url | http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=008288440&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |
| work_keys_str_mv | AT schinaziraymondf therapiesforviralhepatitis |